Gala Renee D sold 1,000 shares of Jazz Pharmaceuticals plc at $225.37 for −$225k on Nov 3, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President & CEO
President & CEO
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$225,370Shares × reported price
Shares traded
1,000Ordinary Shares
Price per share
$225.37Reported price. Read footnotes for ranges.
% of reported position traded
0.71%This security and ownership context
Holdings after
140,394Direct
Trade date
Nov 3, 2026Sell
Filed
Nov 5, 2026, 6:28 PM ET2-day reporting delay
Accession
0001607737-26-000018Code S · Transaction 394024
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 141,394 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

JAZZ price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
JAZZ · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.7%1w ago −9%1d ago −5.7%
Returns since7d +5.7%30d90d180d1y

Footnotes in full

F1: This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.